Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169 - Quiz - MDSpire

Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169

Phase I study will test whether a targeted lentiviral vector can generate BCMA-directed CAR T cells inside patients with multiple myeloma

September 28, 2026
3 min

The Medicine Maker

Share

Original Source(s)

The Medicine Maker

Vyriad Begins First-in-Human Trial of In Vivo CAR T Therapy VV169

September 28, 2026

Related Content

Int. Journal Of Computer Assisted Radiology And Surgery

Deep learning-based segmentation of peritoneal cancer index regions from CT imaging

Journal Of Medical Internet Research

Correction: Lessons Learned From Implementing a Culturally Tailored Virtual Support Program for Asian American Breast Cancer Survivors With Pain and Depression

by Seulgi Ryu, Dongmi Kim, Wonshik Chee, Eun-Ok Im
September 25, 2026

Hemasphere

Decoding cancer-associated ribosomal protein mutations: A new frontier in cancer and ribosome biology

by Mirsada Čaušević, Robbie Loewith, Siniša Volarević
September 25, 2026